Original paperSubstantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987
References (9)
Staging and surgery for colorectal cancer
Eur J Cancer
(1993)
Cited by (40)
Improving cancer control in the European Union: Conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007
2008, European Journal of CancerCitation Excerpt :Survival patterns and trends by age, geography, socio-economic status (etc.) can provide useful indicators of the overall performance of a nation’s health system. Detection of survival that is too low should stimulate more in-depth studies to determine whether this is due to late diagnosis or to inadequate availability of (or poor access to) effective treatment.26–28 These activities are sufficient to justify the establishment and operation of a cancer registry or network of registries in any country.
The Med AUSTRON/ÖGRO patterns of care study on radiotherapy indications in Austria
2004, Radiotherapy and OncologyChanging practices for diagnosis and treatment of colorectal cancer in Calvados: 1990-1999
2004, Gastroenterologie Clinique et BiologiqueEUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century
2003, Annals of OncologyRaltitrexed in the treatment of elderly patients with advanced colorectal cancer: An active and low toxicity regimen
2002, European Journal of CancerCitation Excerpt :In spite of the magnitude of the problem, the treatment of colorectal cancer in elderly patients remains a challenge. Several studies have shown that the proportion of patients with this tumour who are operated upon decreases with age (85% of patients under 65 years versus 70% of older patients) [4]. Furthermore, chemotherapy treatment is also used less frequently in the elderly compared with other age groups, both in the adjuvant [5] and the advanced settings [6].
Treatment outcome studies: Pitfalls in current methods and practice
2002, European Journal of CancerCitation Excerpt :If a registry does not differentiate these cases from invasive carcinoma, a too optimistic estimation of outcome will be obtained for the invasive carcinoma patients. In addition, the staging information routinely available to registries may be incomplete and insufficiently standardised, making more detailed comparisons not always possible [46]. The more accurately patients are staged, the more likely they are to be classified as inoperable or metastatic and therefore, stage by stage, outcome will improve (Will Rogers or stage-migration phenomenon) [30].
- ∗
The EUROCARE working group for this study is: Estonia: T. Aareleid (Estonian Cancer Registry). Finland: T. Hakulinen (Finnish Cancer Registry). France: J. Faivre (Côte d'Or Digestive Cancer Registry), P. Grosclaude (Tarn Cancer Registry), D. Pottier (Calvados Digestive System Cancer Registry), N. Raverdy (Somme Cancer Registry), S. Schraub (Doubs Cancer Registry). Germany: H. Ziegler (Saarland Cancer Registry). Italy: F. Berrino (project leader), G. Gatta, M. Sant (Lombardy Cancer Registry). The Netherlands: J.W.W. Coebergh (Eindhoven Cancer Registry IKZ), R.A.M. Damhuis (Rotterdam Cancer Registry IKK). Poland: J. Pawlega (Cracow Cancer Registry). Switzerland: F. Comba (Genève Cancer Registry), J. Torhorst (Basel Cancer Registry). United Kingdom: J. Bell (Thames Cancer Registry), J. Youngson (Mersey Cancer Registry).